About

Kevin Chu is a Senior Associate on the healthcare team at F-Prime Capital. Prior to F-Prime Capital, Kevin was an Associate Consultant with IMS Consulting Group in New York, where he advised biopharmaceutical clients on development and commercial strategy across multiple therapeutic areas.

Kevin is currently based in the San Francisco office, and works across the healthcare sub-sectors including Therapeutics, MedTech, and Healthcare IT and Services, and also works closely with Eight Roads Ventures China healthcare team to manage F-Prime’s existing and new investment efforts in China.

  • Adagene is an antibody discovery and engineering company with proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody. Learn more at www.adagene.com.

  • b-ONE Ortho Corp. is an emerging orthopedic technology company dedicated to the development of innovative orthopedic healthcare solutions that restore patient mobility and improve surgical outcomes. Every day we are committed to becoming the most credible choice for orthopedic products worldwide. Learn more at http://www.b1.co/.

  • Curegenix is a Chinese leader in discovery and development of novel drugs in stem cell related diseases. Learn more at www.curegenix.com.

    • Category

      • Therapeutics
    • Status

      • Private
    • Location

      China

    • Year Invested

      2016

    • Team

  • Cytek Biosciences Inc. is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capabilities. Learn more at www.cytekbio.com.

    • Category

      • MedTech
    • Status

      • Private
    • Location

      China

    • Year Invested

      2015

    • Team

  • Farapulse is a medical device company developing a novel approach to treating a range of arrhythmias using pulsed electric field. Learn more at www.farapulse.com.

  • Gu Sheng Tang (“GST”) is a Guangzhou, China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine. Learn more at www.gstzy.cn.

    • Category

      • Health IT/Services
    • Status

      • Private
    • Location

      Guangzhou, China

    • Year Invested

      2015

    • Team

  • Huan Qui Li Kang Technology Co., Ltd. (“HQ”) is an early stage hemostatic product manufacturer in China.

  • Hua Medicine (2552.KHK) is a leading clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Learn more at www.huamedicine.com.

  • MDDF is a medical device company focused on the manufacturing, development, and commercialization of high quality, affordably priced cardiovascular and general surgery medical devices for the Chinese market.

     

    • Category

      • MedTech
    • Status

      • Private
    • Location

      Beijing, China

    • Year Invested

      2011

    • Team

  • Medbanks is building a data service platform for oncologists and cancer care centers in China. Learn more at www.medbanks.cn.

  • Modis Therapeutics, Inc. was formed in 2016 through a collaboration with academic experts in mitochondrial biology. The company’s lead program (MT1621) is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. Modis Therapeutics is headquartered in Oakland CA, with offices in New York City. Learn more at www.modistx.com.

    • Category

      • Therapeutics
    • Status

      • Private
    • Location

      Oakland, CA

    • Year Invested

      2018

    • Team

  • TreeENT is a Hangzhou, China-based operator of private, premium-positioned ambulatory surgery centers (ASCs) focused on high volume, high unmet need, and self-pay surgery markets.

    • Category

      • Health IT/Services
    • Status

      • Private
    • Location

      Hangzhou, China

    • Year Invested

      2019

    • Team

  • Zenflow is a medical device company developing the Spring Implant for patients with benign prostate hyperplasia (BPH). Learn more at www.zenflow.com.